Skip to main content
QUIT logo

QUIT · Achieve Life Sciences, Inc. · Debt

Track QUIT — free
$5.73 -0.15 (-2.47%) Play latest call Q1 2026 earnings call transcript
Market Cap
$645.90M
Shares
110.03M
Volume · Nov 20 693.7K Avg daily vol (3M) 1.37M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-09-30 USD 286,000 10-Q filed 2026-11-10
Current portion of convertible debt 2026-09-30 USD 7,454,000 10-Q filed 2026-11-10
Noncurrent convertible debt 2026-09-30 USD 5,595,000 10-Q filed 2026-11-10
Noncurrent operating lease liabilities 2026-09-30 USD 712,000 10-Q filed 2026-11-10
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 949858 13F (30d) 142 filings 123 filers Visit website Investor relations